This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Technology / Lantern Pharma Demonstrates...
Tech product demonstration

Lantern Pharma Demonstrates withZeta.ai Platform

Analysis based on 6 articles · First reported Apr 24, 2026 · Last updated Apr 24, 2026

Sentiment
70
Attention
4
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The public demonstration of Lantern Pharma's withZeta.ai platform is expected to positively impact Lantern Pharma's stock price due to the potential for new recurring revenue streams and accelerated drug discovery in rare cancers. This event highlights the growing influence of AI in the biotechnology and pharmaceutical industries, potentially attracting more investment into AI-driven drug discovery companies.

Biotechnology Pharmaceuticals Artificial intelligence
Event Summary

Lantern Pharma, an AI-driven clinical-stage precision oncology company, will host the first public demonstration of its multi-agentic AI co-scientist platform, withZeta.ai, on April 30, 2026. The demonstration will be led by President and CEO Panna Sharma in a live webinar hosted by RedChip Companies. This event follows the platform's scientific debut at the American Association for Cancer Research Annual Meeting 2026 and its initial unveiling at Nasdaq MarketSite. withZeta.ai is designed to accelerate rare cancer research and drug development, offering a subscription-based commercial model as a new revenue stream for Lantern Pharma. The platform integrates proprietary rare cancer ontology, multi-database querying, and advanced generative AI models for molecular design.

Entities Involved
stock
Lantern Pharma
Lantern Pharma is hosting the public demonstration of its withZeta.ai platform, which is expected to generate a new revenue stream and accelerate cancer therapy development.
Importance 100.0 Sentiment 75.0
per
Panna Sharma
Panna Sharma, President and CEO of Lantern Pharma, will lead the live demonstration of withZeta.ai, showcasing its capabilities as an AI co-scientist.
Importance 90.0 Sentiment 70.0
ngo
American Association for Cancer Research
The American Association for Cancer Research Annual Meeting 2026 was where withZeta.ai made its scientific community debut, validating its scientific rigor.
Importance 20.0 Sentiment 10.0
priv
RedChip Companies
Importance 0.0 Sentiment 0.0
stock
Knight Therapeutics
Importance 0.0 Sentiment 0.0
Relationships
Lantern Pharma client ↔ RedChip Companies Lantern Pharma is a client of RedChip Companies, utilizing the firm's investor relations platform for public demonstrati
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.